Israel Englander Genfit S.A. Call Options Transaction History
Millennium Management LLC
- $224 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GNFT
# of Institutions
7Shares Held
76.8KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY28.5KShares$113,0020.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il16.8KShares$66,8270.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P7963Shares$3,8230.0% of portfolio
-
Rhumbline Advisers Boston, MA678Shares$2,6910.0% of portfolio
-
Qube Research & Technologies LTD London, X098Shares$3890.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $198M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...